会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明专利
    • Iontophoresis apparatus and photodynamic therapy system using iontophoresis apparatus
    • IOPOPHORESIS设备和使用IOPOPHORESIS设备的光电治疗系统
    • JP2007097689A
    • 2007-04-19
    • JP2005288811
    • 2005-09-30
    • Transcutaneous Technologies Incトランスキュー・テクノロジーズ 株式会社
    • KAWAKAMI HIROYOSHISHIBATA TSUTOMUAKIYAMA HIDEONAKAYAMA HATOOMATSUMURA TAKEHIKOMATSUMURA AKIHIKO
    • A61N1/30A61K31/409A61P35/00
    • PROBLEM TO BE SOLVED: To provide an iontophoresis apparatus which can administer photosensitive matter to only a malignant tumor cell. SOLUTION: The iontophoresis apparatus is equipped with an electrode 22A connected to a power source 12, an electrolyte holding section 26A which is arranged in the front of the electrode 22A and holds an electrolyte, an anion exchange membrane 28A which is arranged in the front of the electrolyte holding section 26A and passes an anion selectively, a liquid medicine holding section 30A which is arranged in the front of the anion exchange membrane 28A and holds a photosensitization reactant, a cation exchange membrane 32A which is arranged in the front of the liquid medicine holding section 30A and passes a cation selectively, a working side electrode structure 20A which is arranged in a part on the front side of the cation exchange membrane 32A and has at least a release-inhibiting layer 40 to control the release of the photosensitization reactant, and a position index which is formed in the working side electrode structure 20A and can specify the position of a pasting face 60A to a living body. COPYRIGHT: (C)2007,JPO&INPIT
    • 要解决的问题:提供一种可以将光敏物质仅施用于恶性肿瘤细胞的离子电渗疗法。 解决方案:离子电渗仪装置配备有连接到电源12的电极22A,布置在电极22A的前面并保持电解质的电解质保持部26A,阴离子交换膜28A 电解质保持部26A的前方,通过阴离子选择性地配置在阴离子交换膜28A的前方并保持有光敏性反应物的液体药剂保持部30A,配置在阴离子交换膜28A的前方的阳离子交换膜32A 液体药剂保持部30A选择性地通过阳离子,设置在阳离子交换膜32A的前侧的一部分中的工作侧电极结构20A,并具有至少一个释放抑制层40,以控制阳离子交换膜32A的释放。 光敏反应物和在工作侧电极结构20A中形成的位置指数,并且可以将粘贴面60A的位置指定为 活体。 版权所有(C)2007,JPO&INPIT